Eukaryotic translation

From WikiMD's WELLNESSPEDIA

Eukaryotic translation is the biological process by which messenger RNA (mRNA) is translated into proteins in eukaryotes. It is part of the larger process of protein biosynthesis. The process is complex and involves numerous components and steps.

Overview[edit]

In eukaryotes, translation occurs in the cytoplasm, where the ribosomes are located. Ribosomes are made of a small and large subunit that surround the mRNA. In translation, messenger RNA (mRNA) is decoded to produce a specific polypeptide according to the rules specified by the trinucleotide genetic code.

Initiation[edit]

The initiation of eukaryotic translation involves the assembly of the components of the translation system, which are: the mRNA to be translated, the tRNA that carries the starting amino acid, the two subunits of the ribosome, and the various initiation factors.

The initiation phase begins with the binding of several initiation factors and a special initiator tRNA to the small ribosomal subunit. The mRNA then binds to this complex, followed by the large ribosomal subunit. The assembled initiation complex then begins to scan the mRNA for the start codon.

Elongation[edit]

Elongation is the stage where the amino acid chain gets longer. This stage involves the recognition of the tRNA anticodon, peptide bond formation, translocation, and the repeating of the process until a stop codon is reached.

Termination[edit]

Termination of the eukaryotic translation process occurs when a stop codon (UAA, UAG, or UGA) is encountered. When the ribosome encounters the stop codon, the growing polypeptide is released and the ribosome is disassembled.

Regulation[edit]

The regulation of eukaryotic translation can occur at the initiation phase. The rate of initiation is a major determinant of the rate of protein synthesis. Regulation of translation can impact the global rate of protein synthesis which is closely coupled to the metabolic and proliferative state of a cell.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.